Hypokalemia (Figure 9)
Three out of five studies [5,10,14] reported
investigator-reported hypokalemia, and the pooled analysis revealed that
treatment with Finerenone was associated with a significantly lower risk
of hypokalemia compared to patients treated with placebo (RR = 0.47
[0.38, 0.57] p 0. 00001; I2= 0%).